Player FM 앱으로 오프라인으로 전환하세요!
Performing a Gap Analysis on FDA's Regulatory Protocols
Manage episode 319860659 series 2805302
In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we highlight a number of areas in which the agency’s regulatory oversight could be considered lacking. If the agency incorporated the highlighted ideas from this podcast, might it smooth the pathway to market for some products? Might it enhance communication with the FDA? Could they be welcome additions? Specifically, the following questions are addressed:
- Can you please take a minute to explain why we are dedicating an episode to what’s missing from regulatory and quality systems?
- First topic on the list is communicating with the FDA. Do we need a Wellness Device registration, wellness pre-sub, or wellness device database?
- What about a catch-up 510k and letter to file pre-sub?
- How about a pre-sub for manufacturing issues or to resolve 483s and/or warning letters?
- Let’s jump to regulatory pathway. Is a pathway needed that provides a de novo like version of the PMA?
- Staying in this realm, what about the idea of having substantial equivalence in the Class III and PMA realm?
- What are today’s takeaways in what we may be missing in regulatory and quality systems?
Listen to this episode and see what you think of these regulatory ideas. If you’d like to share thoughts, ask questions, or have a suggestion for a future topic for us to cover, please reach out to me at sfenske@rodmanmedia.com and we’ll see if we want to address your ideas/inquiries/suggestions in a future episode.
For more medtech news and information, visit www.mpomag.com.
144 에피소드
Manage episode 319860659 series 2805302
In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we highlight a number of areas in which the agency’s regulatory oversight could be considered lacking. If the agency incorporated the highlighted ideas from this podcast, might it smooth the pathway to market for some products? Might it enhance communication with the FDA? Could they be welcome additions? Specifically, the following questions are addressed:
- Can you please take a minute to explain why we are dedicating an episode to what’s missing from regulatory and quality systems?
- First topic on the list is communicating with the FDA. Do we need a Wellness Device registration, wellness pre-sub, or wellness device database?
- What about a catch-up 510k and letter to file pre-sub?
- How about a pre-sub for manufacturing issues or to resolve 483s and/or warning letters?
- Let’s jump to regulatory pathway. Is a pathway needed that provides a de novo like version of the PMA?
- Staying in this realm, what about the idea of having substantial equivalence in the Class III and PMA realm?
- What are today’s takeaways in what we may be missing in regulatory and quality systems?
Listen to this episode and see what you think of these regulatory ideas. If you’d like to share thoughts, ask questions, or have a suggestion for a future topic for us to cover, please reach out to me at sfenske@rodmanmedia.com and we’ll see if we want to address your ideas/inquiries/suggestions in a future episode.
For more medtech news and information, visit www.mpomag.com.
144 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.